Assignee
ELITRA PHARMACEUTICALS INC
US·5 granted patents·3 pending applications·86 citations·filing 2000–2003
Top patents by PatentIndex Score
8 records- 0186US6620585B1Use of ectoenzymes and secreted enzymes to monitor cellular proliferationELITRA PHARMACEUTICALS INC·Filed 2000·Granted Sep 16, 2003·23 cites·28 claims
- 0285US6720139B1Genes identified as required for proliferation in Escherichia coliELITRA PHARMACEUTICALS INC·Filed 2000·Granted Apr 13, 2004·26 cites·49 claims
- 0382US6783985B1Gene disruption methodologies for drug target discoveryELITRA PHARMACEUTICALS INC·Filed 2001·Granted Aug 31, 2004·16 cites·29 claims
- 0482US6632636B1Nucleic acids encoding 3-ketoacyl-ACP reductase from Moraxella catarrahalisELITRA PHARMACEUTICALS INC·Filed 2000·Granted Oct 14, 2003·12 cites·14 claims
- 0580US6589738B1Genes essential for microbial proliferation and antisense theretoELITRA PHARMACEUTICALS INC·Filed 2000·Granted Jul 8, 2003·9 cites·12 claims
- 0651US2002045592A1Genes identified as required for proliferation in escherichia coliELITRA PHARMACEUTICALS INC·Filed 2001·Application pending·0 cites
- 0748US2005019931A1Nucleic acids encoding antifungal drug targets and methods of useELITRA PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 0843US2003180953A1Gene disruption methodologies for drug target discoveryELITRA PHARMACEUTICALS INC·Filed 2001·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →